Early mortality rates for ST-segment elevation myocardial infarction in randomized trials have decreased dramatically over the past 20 years, from 13-percent one-month mortality in 1986 to less than 4 percent today.
Patients with peripheral arterial disease (PAD) can benefit from upper-body aerobic exercises, according to a study presented at Scientific Sessions by Diane Treat-Jacobson, Ph.D., R.N., assistant professor at the University of Minnesota School of Nursing, Minneapolis. The findings of the study demonstrated significantly increased maximal walking distance and delayed onset of claudication after aerobic arm exercises.
Erectile dysfunction (ED) medications known as Phosphodiesterase type 5 (PDE-5) inhibitors have been used by millions of men as safe and effective management options associated with high rates of patient and partner satisfaction.
During sleep, freshly minted memories move from the hippocampus, part of the “old” brain, to the neocortex, or “new” brain, for long-term storage. This has been the reigning theory for decades. Brown University research provides the strongest proof yet of this interaction between the old and new brains — and offers surprising evidence that challenges critical details of this theory of learning and memory. Results appear in Nature Neuroscience.
Robert Kass, Ph.D., chairman of the department of Pharmacology at Columbia University Medical Center , will present the latest research on the discovery of a potential molecular culprit for atrial fibrillation (AF), the most common arrhythmias in the human heart, which can be a precursor for stroke.
In the largest review of “broken heart syndrome” patients ever conducted, Mayo Clinic researchers studied 100 patients and found symptoms recurred in 1 out of 10 patients over a four-year period, and that patients experiencing physical stress had a worse survival rate than those under emotional stress.
Max Planck Scientists discover a novel construction principle at the nanoscale which prevents bones from breaking at excessive force.
In the days following a heart attack, patients who have no or mild symptoms and undergo a procedure called angioplasty to mechanically open their totally blocked coronary arteries do not reduce their risk of having another heart attack, going into heart failure or dying, according to the results of a new study.
Researchers today presented data showing that ACTOS (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media thickness in Atherosclerosis using pioglitazone), are part of a late-breaker presentation at the American Heart Association’s Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.
Teenagers do not think they are immortal. But they take risks anyway. Here is why and what we can do about it.